Reviews Optison


No reviews yet.

Optison Drug Description
OPTISON™
(perflutren protein-type A microspheres) Injectable Suspension, USP


WARNING: Serious Cardiopulmonary Reactions
Serious cardiopulmonary reactions, including fatalities, have occurred during
or following perflutren-containing microsphere administration.

Assess all patients for the presence of any condition that precludes
OPTISON administration (see CONTRAINDICATIONS).
In patients with pulmonary hypertension or unstable cardiopulmonary conditions,
monitor vital sign measurements, electrocardiography, and cutaneous oxygen
saturation during and for at least 30 minutes after OPTISON administration
(see WARNINGS).
Always have resuscitation equipment and trained personnel readily available.


DRUG DESCRIPTION
OPTISON™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) is a sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren for contrast enhancement during the indicated ultrasound imaging procedures. The vial contains a clear liquid lower layer and a white upper layer that, after resuspension by gentle mixing, provides a homogeneous, opaque, milky-white suspension for intravenous injection.
Perflutren is chemically characterized as 1,1,1,2,2,3,3,3-perflutren with a
molecular weight of 188, an empirical formula of C3F8
and it has the following structural formula:








Each mL of OPTISON contains 5.0-8.0x108 protein-type A microspheres,
10 mg Albumin Human, USP, 0.22 ± 0.11mg/mL N-acetyltryptophan, and 0.12 mg caprylic0.11
acid in 0.9% aqueous sodium chloride. The headspace of the vial is filled with
perflutren gas. The pH is adjusted to 6.4-7.4. The protein in the microsphere
shell makes up approximately 5­7% (w/w) of the total protein in the liquid.
The microsphere particle size parameters are listed in Table 1.
Table 1: Microsphere Particle Size Parameters


Mean diameter (range)
3.0-4.5µm (max. 32.0µm)


Percent less than 10µm
95%


Last reviewed on RxList: 7/9/2008




Optison Drug Description
OPTISON™
(perflutren protein-type A microspheres) Injectable Suspension, USP


WARNING: Serious Cardiopulmonary Reactions
Serious cardiopulmonary reactions, including fatalities, have occurred during
or following perflutren-containing microsphere administration.

Assess all patients for the presence of any condition that precludes
OPTISON administration (see CONTRAINDICATIONS).
In patients with pulmonary hypertension or unstable cardiopulmonary conditions,
monitor vital sign measurements, electrocardiography, and cutaneous oxygen
saturation during and for at least 30 minutes after OPTISON administration
(see WARNINGS).
Always have resuscitation equipment and trained personnel readily available.


DRUG DESCRIPTION
OPTISON™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) is a sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren for contrast enhancement during the indicated ultrasound imaging procedures. The vial contains a clear liquid lower layer and a white upper layer that, after resuspension by gentle mixing, provides a homogeneous, opaque, milky-white suspension for intravenous injection.
Perflutren is chemically characterized as 1,1,1,2,2,3,3,3-perflutren with a
molecular weight of 188, an empirical formula of C3F8
and it has the following structural formula:








Each mL of OPTISON contains 5.0-8.0x108 protein-type A microspheres,
10 mg Albumin Human, USP, 0.22 ± 0.11mg/mL N-acetyltryptophan, and 0.12 mg caprylic0.11
acid in 0.9% aqueous sodium chloride. The headspace of the vial is filled with
perflutren gas. The pH is adjusted to 6.4-7.4. The protein in the microsphere
shell makes up approximately 5­7% (w/w) of the total protein in the liquid.
The microsphere particle size parameters are listed in Table 1.
Table 1: Microsphere Particle Size Parameters


Mean diameter (range)
3.0-4.5µm (max. 32.0µm)


Percent less than 10µm
95%


Last reviewed on RxList: 7/9/2008




Optison Drug Description
OPTISON™
(perflutren protein-type A microspheres) Injectable Suspension, USP


WARNING: Serious Cardiopulmonary Reactions
Serious cardiopulmonary reactions, including fatalities, have occurred during
or following perflutren-containing microsphere administration.

Assess all patients for the presence of any condition that precludes
OPTISON administration (see CONTRAINDICATIONS).
In patients with pulmonary hypertension or unstable cardiopulmonary conditions,
monitor vital sign measurements, electrocardiography, and cutaneous oxygen
saturation during and for at least 30 minutes after OPTISON administration
(see WARNINGS).
Always have resuscitation equipment and trained personnel readily available.


DRUG DESCRIPTION
OPTISON™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) is a sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren for contrast enhancement during the indicated ultrasound imaging procedures. The vial contains a clear liquid lower layer and a white upper layer that, after resuspension by gentle mixing, provides a homogeneous, opaque, milky-white suspension for intravenous injection.
Perflutren is chemically characterized as 1,1,1,2,2,3,3,3-perflutren with a
molecular weight of 188, an empirical formula of C3F8
and it has the following structural formula:








Each mL of OPTISON contains 5.0-8.0x108 protein-type A microspheres,
10 mg Albumin Human, USP, 0.22 ± 0.11mg/mL N-acetyltryptophan, and 0.12 mg caprylic0.11
acid in 0.9% aqueous sodium chloride. The headspace of the vial is filled with
perflutren gas. The pH is adjusted to 6.4-7.4. The protein in the microsphere
shell makes up approximately 5­7% (w/w) of the total protein in the liquid.
The microsphere particle size parameters are listed in Table 1.
Table 1: Microsphere Particle Size Parameters


Mean diameter (range)
3.0-4.5µm (max. 32.0µm)


Percent less than 10µm
95%


Last reviewed on RxList: 7/9/2008




Optison Drug Description
OPTISON™
(perflutren protein-type A microspheres) Injectable Suspension, USP


WARNING: Serious Cardiopulmonary Reactions
Serious cardiopulmonary reactions, including fatalities, have occurred during
or following perflutren-containing microsphere administration.

Assess all patients for the presence of any condition that precludes
OPTISON administration (see CONTRAINDICATIONS).
In patients with pulmonary hypertension or unstable cardiopulmonary conditions,
monitor vital sign measurements, electrocardiography, and cutaneous oxygen
saturation during and for at least 30 minutes after OPTISON administration
(see WARNINGS).
Always have resuscitation equipment and trained personnel readily available.


DRUG DESCRIPTION
OPTISON™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) is a sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren for contrast enhancement during the indicated ultrasound imaging procedures. The vial contains a clear liquid lower layer and a white upper layer that, after resuspension by gentle mixing, provides a homogeneous, opaque, milky-white suspension for intravenous injection.
Perflutren is chemically characterized as 1,1,1,2,2,3,3,3-perflutren with a
molecular weight of 188, an empirical formula of C3F8
and it has the following structural formula:








Each mL of OPTISON contains 5.0-8.0x108 protein-type A microspheres,
10 mg Albumin Human, USP, 0.22 ± 0.11mg/mL N-acetyltryptophan, and 0.12 mg caprylic0.11
acid in 0.9% aqueous sodium chloride. The headspace of the vial is filled with
perflutren gas. The pH is adjusted to 6.4-7.4. The protein in the microsphere
shell makes up approximately 5­7% (w/w) of the total protein in the liquid.
The microsphere particle size parameters are listed in Table 1.
Table 1: Microsphere Particle Size Parameters


Mean diameter (range)
3.0-4.5µm (max. 32.0µm)


Percent less than 10µm
95%


Last reviewed on RxList: 7/9/2008




Optison Drug Description
OPTISON™
(perflutren protein-type A microspheres) Injectable Suspension, USP


WARNING: Serious Cardiopulmonary Reactions
Serious cardiopulmonary reactions, including fatalities, have occurred during
or following perflutren-containing microsphere administration.

Assess all patients for the presence of any condition that precludes
OPTISON administration (see CONTRAINDICATIONS).
In patients with pulmonary hypertension or unstable cardiopulmonary conditions,
monitor vital sign measurements, electrocardiography, and cutaneous oxygen
saturation during and for at least 30 minutes after OPTISON administration
(see WARNINGS).
Always have resuscitation equipment and trained personnel readily available.


DRUG DESCRIPTION
OPTISON™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) is a sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren for contrast enhancement during the indicated ultrasound imaging procedures. The vial contains a clear liquid lower layer and a white upper layer that, after resuspension by gentle mixing, provides a homogeneous, opaque, milky-white suspension for intravenous injection.
Perflutren is chemically characterized as 1,1,1,2,2,3,3,3-perflutren with a
molecular weight of 188, an empirical formula of C3F8
and it has the following structural formula:








Each mL of OPTISON contains 5.0-8.0x108 protein-type A microspheres,
10 mg Albumin Human, USP, 0.22 ± 0.11mg/mL N-acetyltryptophan, and 0.12 mg caprylic0.11
acid in 0.9% aqueous sodium chloride. The headspace of the vial is filled with
perflutren gas. The pH is adjusted to 6.4-7.4. The protein in the microsphere
shell makes up approximately 5­7% (w/w) of the total protein in the liquid.
The microsphere particle size parameters are listed in Table 1.
Table 1: Microsphere Particle Size Parameters


Mean diameter (range)
3.0-4.5µm (max. 32.0µm)


Percent less than 10µm
95%


Last reviewed on RxList: 7/9/2008





Other reviews about Optison on wordpress

Good to Go Pile . . .
  by misstrade
Gapping up: BEAS +31.9%, PTR +9.9%, ZNH +9.5%, LLNW +7.7%, CHA +6.8%, CEA +6.6%, STV +6.5%, PLCE +5.9%, SEED +4.7%, CTEL +4.8%, AKAM +6.8%... Gapping down: CWTR -19.0%, […]


FDA lists drug safety warning changes
  by drtim
The Food and Drug Administration has issued a list of drugs which required changes in the safety warnings and precautions in NOVEMBER. Remember, the best way to […]


This young woman was possessed of plenti
  by eywihpfjbvg
In the back room Riley and McQuirk toiled like bearded witches over their strange compounds. With my studio furniture and some secondhand stuff we can make out. But […]


But why should I be chased
  by ipcdrivbhxph
The idea that returned the oftenest was that Miss Crawford, after proving herself cooled and staggered by a return to London habits, would yet prove herself in the […]



Other reviews about Optison on web:

All about Optison. View complete and up to date Optison information - part of the Drugs.com trusted medication database. Optison Facts and Comparisons at Drugs.com


Accurate, FDA approved Optison information for healthcare professionals and patients - brought to you by Drugs.com. Optison Official FDA information, side effects and uses.


Learn about the prescription medication Optison (Perflutren Protein-Type A Microspheres), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling Optison (Perflutren Protein-Type A Microspheres) Drug Information ...


OptiSon® Ultrasound Beam Analyzer. Visualize in real time and measure acoustic fields in seconds or minutes. Now you can achieve control of project timing and costs, gain a more ... Ultrasound Beam Analyzer OptiSon by Onda


DESCRIPTION OPTISON ™ (Perflutren Protein-Type A MicrospheresInjectable Suspension, USP) is a sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren ... Serious Cardiopulmonary


Definity and Optison Ultrasound Contrast Agents side effects can cause serious cardiac reactions and deaths, our lawsuit lawyers can help. Definity Lawyers Ultrasound Contrast Agents Lawsuit


Several hundred entries of technical, medical information about medical UltraSound imaging and therapy. The content of these entries is grouped around the following subject areas ... UltraSound TIP - US Database : Optison


Optison (Perflutren Protein-Type A Microspheres for Injection), an ultrasound micro-bubble contrast agent used in echocardiography has recently been linked to Optison® Echocardiogram Lawsuit | Optison Micro-Bubble Contrast ...


Optison® Cardiology A '2 nd-generation' ultrasound contrast medium consisting of a solution of gas-filled microbubbles with a mean bubble size 4 µm, range 1–10 µm produced by ... Optison - definition of Optison in the Medical dictionary - by the ...


Technical Specifications OptiSon S-12D . High Resolution Digital Imaging; Field of view : 9x12 cm to 3x4 cm (zoom 3:1) Image Definition: 1392 x 1040 pixels @ 12 bits Optison Specifications





Featured Reviews

Reviews Albumin

Buminate 5% Drug Description BUMINATE 5% Albumin (Human), USP, 5% Solution This bottle contains 12.5 g albumin from venous plasma in saline and is osmotically equivalent to an equal volume of normal human plasma. It has been stabilized...
Read More  |  Review This
Reviews Dicloxacillin

Dynapen Drug Description Dynapen (dicloxacillin sodium) DRUG DESCRIPTION What are the possible side effects of dicloxacillin (Dycill, Dynapen)? Get emergency medical help if you have any of these signs of an allergic reaction: hives;...
Read More  |  Review This
Reviews Rosiglitazone Maleate

Avandia Drug Description AVANDIA® (rosiglitazone maleate) Tablets WARNING CONGESTIVE HEART FAILURE AND MYOCARDIAL ISCHEMIA Thiazolidinediones, including rosiglitazone, cause or exacerbate congestive heart failure in some...
Read More  |  Review This
Reviews Ticarcillin and Clavulanate

Timentin Drug Description Timentin (ticarcillin disodium and clavulanate potassium) Injection, Powder, For Solution To reduce the development of drug-resistant bacteria and maintain the effectiveness of TIMENTIN (ticarcillin disodium...
Read More  |  Review This
Reviews Busulfan

Busulfex Drug Description BUSULFEX® (busulfan) Injection Caution: Must be diluted prior to use. WARNING BUSULFEX® (busulfan) Injection is a potent cytotoxic drug that causes profound myelosuppression at the recommended...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....